Unknown

Dataset Information

Development of a prognostic nomogram for lymph node positive HR+/HER2- breast cancer patients: a study of SEER database and a Chinese cohort.


ABSTRACT:

Background

The hormone receptor+/human epidermal growth factor receptor 2- (HR+/HER2-) breast cancer (BC) patients account for the largest proportion in all patients and are still at high risk of long-range recurrence. This current study aimed to construct a prognostic nomogram to predict 3-year and 5-year BC-specific survival (BCSS) in HR+/HER2- BC patients with axillary lymph node metastasis.

Methods

A total of 25,338 HR+/HER2- patients with axillary lymph node-positive BC were enrolled from the Surveillance, Epidemiology and End Results (SEER) database and randomly divided into the training (n=17,738) and validation (n=7,600) cohorts using a ratio of 7:3. Univariate and multivariable C

SUBMITTER: Cheng X 

PROVIDER: S-EPMC10721557 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature